Current Research Interests:
Dr. Blinder is a member of the Health Outcomes research Group in the Department of Epidemiology and Biostatistics. She has a secondary appointment in the Department of Medicine as a member of the Breast Cancer Medicine Service. Her main research interest is in evaluating ethnic disparities in quality-of-life outcomes among breast cancer survivors. Her work is currently focused on evaluating possible ethnic differences in barriers to return to work after a breast cancer diagnosis, as well as problems breast cancer survivors may encounter in the workplace. She is also working on a study of uninsured breast cancer survivors in California. Additional research interests include ethnic disparities in breast cancer care, survivorship outcomes, and the economic impact of breast cancer on economically disadvantaged populations.
Selected Bibliography:
- Blinder V, Elul B, Winikoff B. Mifepristone-misoprostol medical abortion: Who will use it and why? American Journal of Obstetrics and Gynecology. 1998, 179(5):1376.
- 2. Gold Gold HT, Hall MJ, Blinder V, Schackman BR. "Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer." Cancer 2009. Accepted for publication.
